Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Главный автор: | Shawn, Ibna Hasan |
---|---|
Другие авторы: | Jamiruddin, Mohd. Raeed |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2024
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/23931 |
Схожие документы
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
по: Chakraborty, Anupama
Опубликовано: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
по: Onanna, Kazi
Опубликовано: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
по: Rahman, Towsifur
Опубликовано: (2024) -
A review on combinatorial therapies in Melanoma
по: Ahmmed, Md. Kawsar
Опубликовано: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
по: Khandker, Tahia Anjum
Опубликовано: (2024)